Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Smolkin

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
Melanoma Research|June 10, 2011
Comprehensive analysis of receptor tyrosine kinase activation in human melanomas reveals autocrine signaling through IGF-1RKerrington R Molhoek, Amber L Shada, Mark Smolkin, et al.
The American Journal of Pathology|January 17, 2009
Profiling bladder cancer organ site-specific metastasis identifies LAMC2 as a novel biomarker of hematogenous disseminationSteven Christopher Smith, Brian Nicholson, Matthew Nitz, et al.
Annals of Surgical Oncology|July 28, 2023
Implementation of a Novel Patient Decision Aid for Women with Elevated Breast Cancer Risk Who Are Considering MRI Screening: A Pilot StudyCrystal D Chu, Caleigh E Smith, Janelle Gorski, et al.
Haematologica|November 14, 2022
Identification of multiple genetic loci associated with red blood cell alloimmunization in miceArijita Jash, Heather L Howie, Ariel M Hay, et al.
International Journal of Radiation Oncology, Biology, Physics|August 12, 2016
A Novel Form of Breast Intraoperative Radiation Therapy With CT-Guided High-Dose-Rate Brachytherapy: Results of a Prospective Phase 1 Clinical TrialShayna L Showalter, Gina Petroni, Daniel M Trifiletti, et al.
Journal for Immunotherapy of Cancer|August 16, 2014
A melanoma helper peptide vaccine increases Th1 cytokine production by leukocytes in peripheral blood and immunized lymph nodesPatrick M Dillon, Walter C Olson, Andrea Czarkowski, et al.
Advances in Immunology|May 30, 2006
Immunity to melanoma antigens: from self-tolerance to immunotherapyCraig L Slingluff, Kimberly A Chianese-Bullock, Timothy N J Bullock, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|July 8, 2005
Autoimmune toxicities associated with the administration of antitumor vaccines and low-dose interleukin-2Kimberly A Chianese-Bullock, Elizabeth M H Woodson, Huimin Tao, et al.
The Journal of Molecular Diagnostics : JMD|July 23, 2004
Allelic imbalance of 8p indicates poor survival in gastric cancerAmy J French, Gina Petroni, Stephen N Thibideau, et al.
Journal for Immunotherapy of Cancer|May 26, 2021
Immunogenicity in humans of a transdermal multipeptide melanoma vaccine administered with or without a TLR7 agonistMax O Meneveau, Gina R Petroni, Elise P Salerno, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Melanoma Research|June 10, 2011
Comprehensive analysis of receptor tyrosine kinase activation in human melanomas reveals autocrine signaling through IGF-1RKerrington R Molhoek, Amber L Shada, Mark Smolkin, et al.
The American Journal of Pathology|January 17, 2009
Profiling bladder cancer organ site-specific metastasis identifies LAMC2 as a novel biomarker of hematogenous disseminationSteven Christopher Smith, Brian Nicholson, Matthew Nitz, et al.
Annals of Surgical Oncology|July 28, 2023
Implementation of a Novel Patient Decision Aid for Women with Elevated Breast Cancer Risk Who Are Considering MRI Screening: A Pilot StudyCrystal D Chu, Caleigh E Smith, Janelle Gorski, et al.
Haematologica|November 14, 2022
Identification of multiple genetic loci associated with red blood cell alloimmunization in miceArijita Jash, Heather L Howie, Ariel M Hay, et al.
International Journal of Radiation Oncology, Biology, Physics|August 12, 2016
A Novel Form of Breast Intraoperative Radiation Therapy With CT-Guided High-Dose-Rate Brachytherapy: Results of a Prospective Phase 1 Clinical TrialShayna L Showalter, Gina Petroni, Daniel M Trifiletti, et al.
Journal for Immunotherapy of Cancer|August 16, 2014
A melanoma helper peptide vaccine increases Th1 cytokine production by leukocytes in peripheral blood and immunized lymph nodesPatrick M Dillon, Walter C Olson, Andrea Czarkowski, et al.
Advances in Immunology|May 30, 2006
Immunity to melanoma antigens: from self-tolerance to immunotherapyCraig L Slingluff, Kimberly A Chianese-Bullock, Timothy N J Bullock, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|July 8, 2005
Autoimmune toxicities associated with the administration of antitumor vaccines and low-dose interleukin-2Kimberly A Chianese-Bullock, Elizabeth M H Woodson, Huimin Tao, et al.
The Journal of Molecular Diagnostics : JMD|July 23, 2004
Allelic imbalance of 8p indicates poor survival in gastric cancerAmy J French, Gina Petroni, Stephen N Thibideau, et al.
Journal for Immunotherapy of Cancer|May 26, 2021
Immunogenicity in humans of a transdermal multipeptide melanoma vaccine administered with or without a TLR7 agonistMax O Meneveau, Gina R Petroni, Elise P Salerno, et al.
Pageof 3